cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Krystal Biotech Inc
4 own
8 watching
Current Price
$80.36
$0.41
(0.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,066.03M
52-Week High
52-Week High
85.65
52-Week Low
52-Week Low
47.67
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,066.03M
icon52-Week High85.65
icon52-Week Low47.67
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Krystal Biotech Inc do?
N/A
Read More
How much money does Krystal Biotech Inc make?
News & Events about Krystal Biotech Inc.
Globe Newswire
30days ago
NEW PDUFA DATE OF MAY 19, 2023PITTSBURGH, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS) today announced that on January 5, 2023, the U.S. Food and Drug Administration(FDA) notified the Company that based on manufacturing information submitted to the Agency on ...
Ticker Report
1month ago
Krystal Biotech, Inc. (NASDAQ:KRYS Get Rating) insider Suma Krishnan sold 1,700 shares of the firms stock in a transaction on Tuesday, January 3rd. The stock was sold at an average price of $80.33, for a total value of $136,561.00. Following the sale, the insider now directly owns 1,...
Globe Newswire
2 months ago
PITTSBURGH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced today that the Company will participate in the Evercore ISI 5th Annual ...
Zolmax
9 months ago
Krystal Biotech (NASDAQ:KRYS Get Rating) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a $71.00 price target on the stock. Zacks Investment Researchs price objective indicates a potential ...
Ticker Report
9 months ago
Krystal Biotech (NASDAQ:KRYS Get Rating) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a $71.00 price target on the stock. Zacks Investment Research&#...
Frequently Asked Questions
Frequently Asked Questions
What is Krystal Biotech Inc share price today?
plus_minus_icon
Can Indians buy Krystal Biotech Inc shares?
plus_minus_icon
How can I buy Krystal Biotech Inc shares from India?
plus_minus_icon
Can Fractional shares of Krystal Biotech Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Krystal Biotech Inc stocks?
plus_minus_icon
What is today’s traded volume of Krystal Biotech Inc?
plus_minus_icon
What is today’s market capitalisation of Krystal Biotech Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Krystal Biotech Inc?
plus_minus_icon
What percentage is Krystal Biotech Inc down from its 52-Week High?
plus_minus_icon
What percentage is Krystal Biotech Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$80.36
$0.41
(0.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
TRANSMEDICS GROUP INC
TRANSMEDICS GROUP INC
$67.85
$1.77 (2.68 %)
ImmunityBio Inc.
ImmunityBio Inc.
$4.32
$-0.01 (-0.23 %)
Outset medical Inc
Outset medical Inc
$29.49
$0.45 (1.55 %)
AdaptHealth Corp
AdaptHealth Corp
$20.65
$0.51 (2.53 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
TRANSMEDICS GROUP INC
TRANSMEDICS GROUP INC
$67.85
$1.77 (2.68 %)
ImmunityBio Inc.
ImmunityBio Inc.
$4.32
$-0.01 (-0.23 %)
Outset medical Inc
Outset medical Inc
$29.49
$0.45 (1.55 %)
AdaptHealth Corp
AdaptHealth Corp
$20.65
$0.51 (2.53 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00